Stem Cell Research & Therapy
Scope & Guideline
Unlocking the Potential of Stem Cells for Tomorrow
Introduction
Aims and Scopes
- Stem Cell Characterization and Mechanisms:
Research articles often explore the biological characteristics, differentiation potential, and mechanisms of action of various types of stem cells, including mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and other progenitor cells. - Therapeutic Applications of Stem Cells:
The journal publishes studies on the clinical applications of stem cells in treating a variety of diseases and conditions, such as autoimmune disorders, cardiovascular diseases, and neurological conditions, emphasizing their potential in regenerative medicine. - Extracellular Vesicles and Secretome:
A significant focus is placed on the role of stem cell-derived extracellular vesicles and secretomes, highlighting their therapeutic potential in modulating immune responses, enhancing tissue repair, and their applications in drug delivery. - Innovative Techniques in Stem Cell Research:
The journal features advancements in methodologies for stem cell isolation, culture, and differentiation, including bioprinting, 3D culture systems, and genetic engineering techniques like CRISPR/Cas9. - Interdisciplinary Approaches in Stem Cell Therapy:
Research often integrates approaches from molecular biology, immunology, and bioengineering to address challenges in stem cell therapy, including issues related to cell survival, engraftment, and immune modulation.
Trending and Emerging
- Regenerative Medicine and Tissue Engineering:
There is a growing emphasis on the use of stem cells in regenerative medicine and tissue engineering, with numerous studies focusing on their ability to repair and regenerate damaged tissues and organs, particularly in orthopedic and cardiovascular applications. - Stem Cell-Derived Exosomes and Their Therapeutics:
Research on exosomes derived from stem cells is rapidly increasing, highlighting their potential as a cell-free therapeutic strategy for various diseases, including cancer, cardiovascular diseases, and neurodegenerative conditions. - Immunomodulatory Properties of Stem Cells:
The immunomodulatory effects of stem cells, especially in the context of inflammatory diseases and transplant rejection, are gaining attention, as studies explore how stem cells can modulate immune responses to enhance therapeutic outcomes. - Personalized Stem Cell Therapies:
There is a trend towards personalized approaches in stem cell therapies, including the use of patient-derived iPSCs to create tailored treatments for individual patients, particularly in genetic disorders and cancer. - Stem Cell Therapy for COVID-19 and Other Acute Conditions:
The journal has seen an increase in research focusing on the application of stem cell therapies in treating COVID-19 and other acute conditions, exploring their potential in immune modulation and tissue repair.
Declining or Waning
- Traditional Stem Cell Sources:
There has been a noticeable decrease in studies focusing on traditional sources of stem cells, such as bone marrow and embryonic stem cells, as research increasingly shifts towards more versatile and ethically favorable sources, such as iPSCs and MSCs from various tissues. - Basic Stem Cell Biology:
Research that solely focuses on basic stem cell biology without direct clinical applications appears to be declining. The trend is moving towards more translational studies that emphasize therapeutic implications and clinical outcomes. - End-of-Life Applications of Stem Cells:
The exploration of stem cell therapies for end-of-life conditions has decreased, as the journal emphasizes more on regenerative applications and therapeutic interventions that can significantly improve patient outcomes.
Similar Journals
Russian Journal of Developmental Biology
Illuminating the pathways of biological growth.The Russian Journal of Developmental Biology, published by PLEIADES PUBLISHING INC, serves as a significant platform for researchers and professionals engaged in the field of developmental biology. With the ISSN 1062-3604 and E-ISSN 1608-3326, this journal focused on intricate biological processes and dynamic developmental mechanisms from 2005 until 2017. Although its coverage is currently discontinued in Scopus, it remains notable for its contribution to understanding the pivotal roles of biochemistry and molecular genetics within the context of development. As a publication situated in the competitive quartiles of the field and boasting an influential Scopus rank of #77 out of #78, it has made a unique mark in developmental studies. Researchers and academics seeking to enhance their knowledge of historical advancements in the discipline will find the journal a valuable resource, even as it navigates the transition away from active publication.
CELL PROLIFERATION
Advancing the Frontiers of Cellular ResearchCELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.
International Journal of Stem Cells
Advancing the Frontiers of Stem Cell ResearchThe International Journal of Stem Cells is a distinguished peer-reviewed journal dedicated to advancing the field of stem cell research. Published by the Korean Society for Stem Cell Research, this journal has established itself as a vital source of high-quality research since its inception in 2008. Operating under the ISSN 2005-3606 and E-ISSN 2005-5447, the journal caters to a global audience, featuring works that span a diverse array of topics within Cell Biology and Developmental Biology. It is noteworthy that as of 2023, the journal is ranked Q3 in Cell Biology and Q2 in Developmental Biology, highlighting its growing influence and credibility in the scientific community. Given its commitment to facilitating open scientific communication, it is crucial for researchers, professionals, and students to engage with the rigorous research published in this journal as it profoundly impacts the understanding and application of stem cell science. With accessibility to a wealth of innovative studies, the International Journal of Stem Cells remains an indispensable resource for anyone interested in the transformative potential of stem cell research.
Cellular and Molecular Bioengineering
Transforming Ideas into Solutions in Cellular BioengineeringCellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.
Stem Cell Research
Bridging discovery and clinical innovation.Stem Cell Research is a premier Open Access journal published by ELSEVIER, dedicated to advancing the understanding of stem cell biology. Since its inception in 2007, the journal has provided a platform for the latest research in the fields of Cell Biology, Developmental Biology, and Medicine, with its publication being accessible globally since 2014. Located in the Netherlands, the journal’s comprehensive scope aims to bridge fundamental discoveries with clinical applications, fostering collaboration among researchers and professionals. With a 2023 impact factor reflected in its Q4 ranking in Cell and Developmental Biology and a commendable position in the 64th percentile for General Medicine, Stem Cell Research remains a vital resource for those interested in the dynamic landscape of regenerative medicine. Targeting an audience that includes researchers, practitioners, and students, the journal emphasizes not only the significance of stem cells in medical science but also the ethical considerations and the public discourse surrounding stem cell research. Join the community committed to pioneering the future of stem cell science through rigorous peer-reviewed research.
DIFFERENTIATION
Shaping the Future of Developmental ResearchDIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.
Inflammation and Regeneration
Uncovering the links between immune response and tissue regeneration.Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.
Stem Cell Reviews and Reports
Bridging Knowledge Gaps in Cell BiologyStem Cell Reviews and Reports is a prestigious journal published by SPRINGER specializing in the dynamic field of stem cell research, encompassing various aspects of cell biology and cancer research. With an ISSN of 2629-3269 and E-ISSN of 2629-3277, this journal serves as an essential resource for academics, offering insightful reviews and cutting-edge reports from 2009 to 2024. The journal has achieved a commendable Q2 ranking in both Cancer Research and Cell Biology categories as of 2023, highlighting its significant contribution to the scientific community. Additionally, with Scopus rankings placing it in the 74th percentile for both biochemistry and cell biology, it is recognized for its high-quality articles that foster innovative approaches in stem cell therapy and regenerative medicine. As an Open Access publication, Stem Cell Reviews and Reports ensures that its comprehensive content is readily available to researchers, professionals, and students, promoting collaboration and advancement in this vital area of study.
Regenerative Therapy
Unlocking potential in biomaterials and developmental biology.Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.
Cellular Reprogramming
Transforming Insights into Breakthroughs in BiotechnologyCellular Reprogramming is a prominent academic journal published by MARY ANN LIEBERT, INC, dedicated to advancing the field of cellular biology and biotechnology. With its ISSN 2152-4971 and E-ISSN 2152-4998, this journal provides an innovative platform for researchers and professionals to share groundbreaking research findings on cellular reprogramming, stem cell biology, and regenerative medicine. Established in 2010, and actively publishing until 2024, the journal is recognized for its contributions, evidenced by its categorizations in the Q3 and Q4 quartiles across several related fields, including biotechnology and developmental biology. This peer-reviewed journal not only supports open access to scientific literature but also aims to enhance interdisciplinary collaboration among scientists. With a growing impact in the realms of biochemistry, genetics, and molecular biology, Cellular Reprogramming remains an essential resource for the dissemination of pioneering research that could shape the future of cellular therapies.